Hépatite C chez les usagers de drogues par voie veineuse : exploration des barrières et des facilitants pour l’accès aux soins et services (notice n° 1578737)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 04352cam a2200397 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20251228045517.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Foley, Véronique |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Hépatite C chez les usagers de drogues par voie veineuse : exploration des barrières et des facilitants pour l’accès aux soins et services |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2016.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 42 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Objectif : Cette étude explore les facteurs qui favorisent ou nuisent à la prévention, au dépistage et au traitement de l’hépatite C selon la perspective des personnes concernées par l’hépatite C. Elle vise à proposer des pistes de solution pour réduire les barrières d’accès aux soins et services de santé. Méthodes : Dans le cadre d’une recherche évaluative, nous avons effectué une analyse qualitative thématique de quatre focus group menées auprès des personnes concernées par l’hépatite C. Deux entrevues (n = 3) étaient composées de personnes à risque de contracter l’hépatite C, la troisième (n = 6) rejoignait des personnes diagnostiquées porteuses du VHC, mais non traitées et la quatrième (n = 6) intégrait des personnes ayant eu accès au traitement (n = 6). Résultats : Nous identifions les déterminants, barrières et facteurs facilitants, des trajectoires de santé et de soins des personnes infectées par l’hépatite C ou à risque de l’être selon deux périodes de vie : de l’injection au dépistage pour le VHC et du diagnostic au traitement. Les trajectoires de vie relativement à l’hépatite C sont le produit de plusieurs influences : l’expérience vie personnelle, l’attitude du personnel de soins, l’organisation du système de santé et de facteurs contingents. Conclusion : Mieux comprendre l’expérience de vie des personnes concernées par l’hépatite C est nécessaire pour identifier les leviers possibles et penser l’organisation du système de santé de façon à ce qu’il rejoigne plus efficacement ces personnes. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Hepatitis C in intravenous drug users: study of obstacles and facilitators to access to health care and services Objective: The study was designed to document the experiences of people affected by hepatitis C with respect to prevention, screening and treatment to more clearly understand the determinants of health trajectories and access to the health system. Methods: Based on an evaluative research, we conducted a thematic qualitative analysis of four focus group interviews with people affected by hepatitis C. Two interviews (n = 3) consisted of people at risk of contracting hepatitis C, the third interview (n = 6) concerned people diagnosed HCV positive but not treated and the fourth interview (n = 6) targeted people who had access to treatment (n = 6). Results: We identified the drivers, barriers and facilitating factors, trajectories of health and care of people affected by hepatitis C in two periods of life: from the injection to HCV screening and from HCV diagnosis to treatment. Life trajectories in relation to hepatitis C are the product of many influences: the personal life experience, the attitude of healthcare staff, the organization of the health system and contingent factors. Conclusion: Understanding the life experience of people affected by hepatitis C is essential to identify potential levers of change and new ways to organize the health system in order to more effectively reach these people. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | consommateurs de substances à des fins non thérapeutiques |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | dépistage |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | disparité d’accès aux soins |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | hépatite C |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | prévention |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | recherche qualitative |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | traitement |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | drug users |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | healthcare disparities |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | hepatitis C |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | prevention |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | qualitative research |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | screening |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | treatment |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Petit, Geneviève |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Giraud, Marie-Josée |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Boisvert, Krystel |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rietmann, Michèle |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Brousselle, Astrid |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Santé Publique | 28 | 3 | 2016-06-08 | p. 363-374 | 0995-3914 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://stm.cairn.info/revue-sante-publique-2016-3-page-363?lang=fr&redirect-ssocas=7080">https://stm.cairn.info/revue-sante-publique-2016-3-page-363?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux